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It has recently become possible to recognize 
subpopulations of lymphocytes. Those responsible 
for cell-mediated immunity are called T -lym-
phocytes because they are dependent on the thy-
mus for their normal functioning. Other lympho-
cytes are called B-Iymphocytes and they are 
involved in antibody formation. B-Iymphocytes 
can be recognized by their surface immunoglobu-
lins and their receptors for the third component of 
complement (C3) and aggregated IgG. T-cells 
respond by mitosis to phytohemagglutinin (PHA) 
and concanavalin A; B-Iymphocytes do not. T-
lymphocytes form rosettes with sheep erythro-
cytes; B-Iymphocytes do not. About 70 to 80% of 
lymphocytes in peripheral blood are T -cells . The 
remaining 20 % are B-Iymphocytes. 
The primary immunodeficiency disorders can be 
viewed as defects or deficits in T -cells or B-cells or 
both. On this basis, a committee of the World 
Health Organization has attempted to classify the 
primary immunodeficiency disorders (Tab.). 
There are multiple skin manifestations of these 
various syndromes . 
INFANTILE X-LINKED AGAMMAGLOBULINEMIA 
Male infants with agammaglobulinemia usually 
remain well during the first 9 months of life, 
probably because of passive protection afforded by 
the maternal gamma globulin. Undue susceptibil-
ity to infection becomes evident during the second 
year of life. However, depending on the environ-
ment of the child, the presence of older siblings , 
and other circumstances, the onset of frequent 
infection may be even further delayed. These 
children almost invariably contract infection with 
pyogenic organisms, principally staphylococci, 
pneumococci, streptococci, and Hemophilus 
influenzae. The infections are usually readily con-
trolled with antimicrobial chemotherapy. Purulent 
sinusitis, pneumonia, sepsis, meningitis, and otitis 
media are the most common types of infection. 
They may be persistently recurrent until proper 
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prophylactic therapy is undertaken. Untreated, 
many of these children develop chronic progressive 
bronchiectasis and ultimately die of the pulmonary 
complications if they survive the innumerable 
infections . 
Agammaglobulinemic children do not have in-
creased susceptibility to the common viral diseases 
and exanthems of childhood. They usually sustain 
measles, mumps, varicella, and rubella in ordinary 
fashion. The enterobacilli are not usually invasive 
in affected children. Death from Pseudomonas 
aeruginosa sepsis has been noted, however. Several 
deaths from Pneumocystis carinii have been re-
ported in agammaglobulinemic infants and young 
children. Some patients have been successfully 
treated with pentamidine isothionate. A majority 
of affected boys develop arthritis, particularly of 
the large joints. This complication disappears once 
replacement therapy with gamma globulin is 
begun. 
The study of a large number of kindred with 
multiple occurrences of congenital agammaglobu-
linemia has revealed an X-linked pattern of inheri-
tance . In addition to the occurrence of the disease 
in brothers, the diagnosis has been established in 
boys whose sisters subsequently had male offspring 
with the disease. 
The serum of children with congenital agamma-
globulinemia contains less that 100 mg of IgG per 
100 ml. Serum IgA and IgM concentrations are 
usually less that 1 % of normal adult values. The 
isohemagglutinin levels are low or nil. A positive 
reaction to the Schick test in the presence of a 
history of diphtheria-pertussis-tetanus immuniza-
tion can be elicited. Antigenic stimulation with 
any number of antigens fails to provoke an anti-
body response. With exquisitely sensitive methods 
of antibody measurement, very low levels of anti-
body to certain animal viruses and phage particles 
can sometimes be demonstrated. Apparently, the 
small amount of gamma globulin present in the 
serum is not "inert." 
It is not uncommon to observe either leukopenia 
or striking leukocytosis in patients with agamma-
globulinemia at the time of severe pyogenic infec-
tions. Lymphocyte counts are normal (more than 
2,000 cells per mm 3). Delayed hypersensitivity 
reactions of both the tuberculin and the skin-con-
tact type are intact, although perhaps quantita-
tively reduced in some patients. The former can be 
universally demonstrated with intradermally in-
jected Candida antigen, with killed vaccinia virus 
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TABLE. Primary immunodeficiency disorders 
Suggested cellular defect lnheritance 
Type B-cells T-cells X-linked Auto- OtherC 
somal 
Circulating reces-
Ig-bearing sive 
B-lymphocytes 
(a)a (b)b 
X-linked agammaglobulinemia X (X)d X 
Thymic hypoplasia X X 
Severe combined immunodeficiency X X X X X X 
with dysostosis X ? X X 
with ADA deficiency X X X 
with generalized 
hematopoietic hypoplasia X X X 
Selective Ig deficiency 
IgA deficiency ? X (X) X 
Others ? X 
X-linked immunodeficiencies-increased IgM X X 
Immunodeficiency with ataxia-telangiectasia X X X 
Immunodeficiency with thrombocytopenia and eczema 
(Wiskott-Aldrich syndrome) X X 
Immunodeficiency with thymoma xa X X 
Immunodeficiency with normal or hypergammaglobulinemia X X (X) X 
Transient hypogammaglobulinemia of infancy X X 
Variable immunodeficiencies 
(largely unclassified and very frequent) X X (X) (X) X 
a Absent or very low 
b Easily detectable or increased 
C Implies multifactorial or unknown genetic basis or no genetic basis 
d Some cases with circulating B-Iymphocytes without detectable surface Ig have been found 
after vaccination, or with tuberculin after infection 
with bacillus Calmette-Guerin (BCG), and the 
latter with dinitrochlorobenzene (DNCB) applied 
to the skin as a patch test after suitable provoca-
tion with a vesicant dose of DNCB. The response of 
peripheral blood~ lymphocytes to PHA is normal, 
and these cells make normal amounts of macro-
phage inhibitory substance. In sum, there is no 
demonstrable T-cell deficit in affected boys. Allo-
graft rejection is also intact. Peripheral blood 
contains normal numbers of T -cells [1]. 
The sine qua non of the diagnosis of X-linked 
agammaglobulinemia is the demonstration that 
there are no plasma cells in lymph nodes stimu-
lated with antigen. The basic defect in the disease 
is, in fact, the absence of plasma cells from the 
lymph nodes, spleen, intestine, and bone marrow. 
It has been noted that bone marrow is not a reliable 
locus to ascertain whether or not plasma cells are 
present in normal numbers in young children [2]. 
B-cells are absent from peripheral blood [3]. We 
have found only one case with normal numbers of 
B-cells in a blood sample [4] . In addition to the 
absence of plasma cells from the usual sites, 
disorganization of the lymphoid tissue is apparent. 
No normal follicular organization of the lympho-
cytes is apparent. Hypoplasia of the tonsils seen on 
examination of the oropharynx is an important 
clue to the diagnosis . The paucity of adenoid tissue 
results in a widened airway in lateral-view x-ray 
studies of the nasopharynx. Hyperplasia of the 
reticulum cells is apparent in patients with agam-
maglobulinemia and may become so striking as to 
produce persistent lymphadenopathy in older 
patients. The thymus gland is normal. 
The injection of gamma globulin has proved to be 
effective in preventing the severe recurrent pyo-
genic infections sustained by these patients. The 
effective prophylactic dose of gamma globulin was 
found empirically. If the serum level is raised by 
approximately 200 mg per 100 ml, invasive bacte-
rial infections can be prevented. To achieve the 
desired level, the patient with a newly diagnosed 
disorder is given 1.8 ml, or 300 mg, of gamma 
globulin per kg of body weight, usually in 3,divided 
doses of 0.6 ml (100 mg) per kg. This raises the 
serum concentration by about 300 mg per 100 ml. 
Since the half-life of the gamma globulin injected 
is 30 days or more in these patients, they must 
receive a monthly injection of 0.6 ml (100 mg) per 
kg to maintain the desired level of approximately 
200 mg per 100 ml. Smaller doses are ineffective. 
We have not found it necessary to give prophy-
lactic antibiotics to these patients who are receiv-
ing monthly injections of adequate doses of gamma 
globulin. Antibiotic therapy is used to treat spe-
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cific infections that may supervene, and these 
respond satisfactorily to such therapy. 
Standard gamma globulin fractions cannot be 
given intravenously; severe pyogenic and cardi-
ovascular reactions follow intravenous injection in 
many recipients, particularly those who are acutely 
ill. The noxious effects have been attributed to 
aggregation of small amounts of gamma globulin 
during preparation procedures. Barandun noted 
that patients with antibody deficiency syndromes 
tend to have a high incidence of adverse reactions 
to intravenously injected gamma globulin. Ninety-
three percent of them had such reactions, whereas 
only 13% of other subjects exhibited untoward 
effects after intravenous administration. When 
such reactions have been experienced, the patient 
remains in a tolerant or refractory state for 4 or 5 
days upon further intravenous challenge. The more 
pronounced the reaction, the more lasting the 
tolerance. During intravenous infusion, reactors 
first experience tachycardia and respiratory dis-
tress, facial flushing, a sensation of pressure in the 
chest, and flank pain. These initial symptoms are 
followed by chills, fever, pallor, and malaise. In 
more severe reactions, nausea, vomiting, and cir-
culatory collapse occur. 
Commercial preparations of gamma globulin 
contain, relatively, trace amounts of IgA and IgM. 
No preparation of these immunoglobulins is cur-
rently available for clinical use. To circumvent this 
difficulty, whole plasma infusion by a "buddy 
system" has been successfully used to achieve 
prophylaxis against infection. 
TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY 
The human fetus is capable of forming anti-
bodies in utero when adequately stimulated after 
the 20th week of gestation. Intrauterine infection 
with syphilis, cytomegalovirus, rubella virus, or 
Toxoplasma results in fetal antibody synthesis. 
The antibodies synthesized by the human fetus are 
mainly IgM and at times IgA. 
In normal circumstances, the full-term human 
newborn infant is endowed with maternal IgG so 
that umbilical cord serum contains a quantity of 
gamma globulin similar to that of the maternal 
serum. Infants born of agammaglobulinemic moth-
ers have no discernible gamma globulin in cord 
serum. Virtually no maternal IgA and very little 
maternal IgM traverses the placenta into the fetal 
circulation. The cord blood contains less than 1 % 
of the maternal serum levels of IgA, IgD, and IgE, 
and about 10% of the maternal IgM level. 
The transplacental passage of gamma globulin 
begins in the 3rd or 4th month of fetal life. 
Although amniotic fluid contains 20 to 30 mg per 
100 ml of IgG, there is no direct evidence that this 
gamma globulin enters the human fetal circulation 
in significant amounts. It is noteworthy that a 
sizable amount of maternal gamma globulin leaks 
from the fetal circulation into the fetal intestinal 
lumen and provides the newborn infant with intes-
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tinal irrimunity, which can render early oral poli-
omyelitis immunization ineffective if the mother 
has a high titer of poliomyelitis antibody. 
The transplacental passage of IgG appears to 
involve an active transport system in the placenta 
which recognizes some specific structural attribute 
of the Fc fragment. Studies with radioiodinated 
proteins injected into pregnant women near term 
confirm this conclusion. There is no substantial 
evidence that maternal colostral antibody is ab-
sorbed in significant quantity from the intestine of 
the newborn infant. There is evidence, however, 
that breast feeding provides the infant with intesti-
nal immunity and that the IgA molecules survive 
passage in part through the gastrointestinal tract. 
The newborn infant starts synthesizing IgM 
antibodies at birth, and IgM levels rise rapidly; by 
the end of the first year of life, the infant has 
normally close to 75% of normal adult IgM levels. 
The newborn infant can also synthesize IgA by the 
3rd week of life. The level of this group of globulins 
tends to rise more slowly and reaches up to 75% of 
normal adult values by the end of the second year. 
Thereafter, the level rises very slowly throughout 
childhood. However, IgA appears in secretions 
such as tears by age 3 weeks. The maternal IgG is 
slowly catabolized, so that the infant's serum IgG 
level reaches its low point of approximately 300 mg 
per 100 ml by the end of the 2nd month of life when 
infants begin to synthesize IgG. Serum levels ofIgG 
rapidly rise toward normal adult valu~s by the end 
of 1 year of age. 
No plasma cells can ordinarily be found in the 
normal newborn infant although cord blood con-
tains a normal number of B-cells. As the infant 
matures immunologically, there is concomitant 
maturation of the lymphoid tissue, with organiza-
tion of follicles and the appearance of plasma cells 
during the 3rd month of life. In certain cases, there 
is an abnormally prolonged delay in the onset of 
gamma globulin synthesis by the infant. This 
unphysiologic event has been designated tra~nsient 
hypogammaglobulinemia. It occurs equally in 
males and females. These infants usually recover 
from this incapacity between 18 and 30 months of 
age. However, before the onset of normal immuno-
globulin synthesis, infants with transient hypo-
gammaglobulinemia may display an undue sus-
ceptibility to infections of the skin, meninges, or 
respiratory tract, usually owing to infection with 
gram-positive organisms. Recurrent otitis media, 
bronchiolitis, and bronchitis are the most common 
infections in such infants. Multiple cases in a 
single family have been observed. Despite the 
presence of normal numbers of B-cells in periph-
eral blood, lymph nodes display very small or no 
germinal centers and few, if any, plasma cells. 
Cellular immunity is intact. The rapid onset of 
normal B-cell function in these infants suggests 
that this disease is analogous to allotypic suppres-
sion of antibody formation -in rabbits. However, no 
evidence has yet been forthcoming to document 
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this possibility. A search for Gm agglutinators in 
affected infants and their mothers has not revealed 
a consistent abnormality. 
SELECTIVE IMMUNOGLOBULIN DEFICIENCIES 
The development of immunoelectrophoretic 
techniques led to a more precise definition of 
immunoglobulin defects in several situations in 
which the hypogammaglobulinemia involved one 
or two of the immunoglobulin groups, while levels 
of the others were normal or elevated. Six com-
binations of the deficits of the three major immu-
noglobulins are obviously possible, although only 
two of these have been reported extensively. There 
have been many attempts to classify these abnor-
malities, and at present it is more confusing and 
less helpful to abide by one or another system of 
designations than to describe the immunoelectro-
phoretic stigmata of the defect under discussion. It 
has been estimated that about 1 in 200 random 
hospital admissions represents some form of selec-
tive immunoglobulin deficiency. 
The isolated absence of IgA from the serum 
occurs in a significant (4 to 7 per 1000) but small 
proportion of the normal population. Two healthy 
researchers have found their own serum to lack 
IgA. IgA deficiency has been associated with stea-
torrhea and nontropical sprue. Such patients lack 
IgA-producing cells in the lamina propria of the 
intestinal tract where such cells are normally found 
in greatest abundance. Other patients with con-
nective tissue disease and nontropical sprue and 
about 80% of patients with ataxia-telangiectasia 
lack serum and secretory IgA [5-8]. 
Although familial lack of IgA is well docu-
mented, the mode of inheritance of the defect is 
not clearly established. Several patients with ab-
sence of IgA have circulating anti-IgA antibodies 
which may result in rapid catabolism of IgA and 
plasma transfusion reactions [9 J. 
Selective IgM deficiency has been associated 
with septicemia in the few cases reported. Selec-
tive IgG subclass deficiencies have also been found 
in patients with chronic progressive bronchiectasis 
[10 J. A high incidence of collagen disease has been 
noted in patients with such selective immunoglob-
ulin defects, particularly IgA deficiency. Despite 
serum IgA deficiency, normal numbers of IgA-
fluorescent B-cells are present in the blood. 
X-LINKED IMMUNODEFICIENCY WITH HYPER-IGM 
One of the most common partial immunoglobu-
lin defects is characterized by a deficiency of IgA 
and IgG and increased amounts of IgM in the 
serum [11, 12 J. The IgM levels range from 150 to 
1000 mg per 100 ml in these patients. Despite the 
enormous elevations of the IgM levels, the IgM 
does not form an M component. The IgM appears 
to be composed of normally distributed molecules 
with antibody activity, particularly those associ-
ated with the macroglobulins, and to have a 
normal distribution of kappa and lambda chains. 
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Several, but not all, of these patients have had an 
elevation of the serum IgD and IgM subunits. In 
addition to their undue susceptibility to infection, 
many of these patients acquire thrombocytopenia, 
neutropenia, renal lesions, and aplastic and hemo-
lytic anemia, presumably manifestations of 
autoimmune processes. In one case, this was well 
documented to involve the N antigen of the red 
blood cell. Administration of exogenous IgG has 
not been generally noted to decrease IgM levels, 
although it did ameliorate the severe neutropenia 
in a boy and in a recent report, the IgM level was 
decreased by exogenous IgG. 
The defect can apparently be inherited as an 
X-linked phenomenon. In one instance, 4 boys of 
one kindred and 2 boys of another were reported to 
have this defect, and identical twins are known to 
be affected. Several of the cases have been found in 
adult females and older girls, in whom the defect 
appears to be a primary acquired form. 
Patients with this syndrome frequently develop 
a malignant infiltrative process of IgM-producing 
cells which proves fatal. Although it usually starts 
in the gastrointestinal tract, all the viscera are 
ultimately involved. Hyper-IgM with immunodefi-
ciency has frequently been associated with con-
genital rubella. 
COMMON, VARIABLE, OR " ACQUIRED" 
AGAMMAGLOBULINEMIA 
Shortly after the initial description of congenital 
agammaglobulinemia, an acquired form of the 
disease was described in adults. The acquisition of 
agammaglobulinemia has been documented in 
several patients, but close observation has not 
revealed the cause for this sudden depression of 
gamma globulin synthesis. 
Primary acquired agammaglobulinemia has 
been found equally in males and females. Although 
there is no clear-cut genetic influence on the 
occurrence of primary acquired agammaglobulin-
emia, multiple cases in a single kindred have been 
reported. There has been a high ~ncidence of other 
immunologic abnormalities in relatives of patients 
with acquired agammaglobulinemia, such as lupus 
erythematosus, hemolytic anemia, positive rheu-
matoid factor tests , and thrombocytopenic pur-
pura [13]. 
Undue susceptibility to pyogenic infection, par-
ticularly recurrent sinusitis and pneumonia, is a 
prominent clinical feature of acquired agamma-
globulinemia. Patients with chronic progressive 
bronchiectasis should be prime suspects for the 
diagnosis of acquired agammaglobulinemia. A 
prominent and frequent complication of acquired 
agammaglobulinemia, which is almost never seen 
in the congenital disease, is a sprue-like syndrome. 
Diarrhea, steatorrhea, at times protein-losing 
enteropathy, and a whole range of malabsorption 
difficulties afflict more than half of all adults with 
acquired agammaglobulinemia. An intestinal bi-
opsy is rarely rewarding, for, more often than not, 
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the characteristic flattening of the villi seen in 
nontropical sprue is absent, and the biopsy 
appears to be perfectly normal. In some instances, 
nodular lymphoid hyperplasia has been reported. 
Some of these patients have improved on a gluten-
free diet, and others upon elimination of milk from 
the diet. The most helpful therapy is found only by 
trial and error. Giardia Lamblia is very frequently 
discovered in duodenal biopsies. A short course of 
Flagyl therapy usually eliminates the gastrointes-
tinal symptoms [14]. The arthritis so frequently 
seen in the congenital form of the disease is rarer in 
the acquired disease. 
Another distinguishing feature of the acquired 
form of the disease is the frequent occurrence of 
noncaseating granulomas. The lungs, spleen, skin, 
and liver are most frequently involved. No micro-
organisms have been found consistently in these 
lesions. Steroid therapy has been helpful. A num-
ber of patients with acquired agammaglobulinemia 
have splenomegaly, or hepatosplenomegaly, and 
lymphadenopathy. The complications of hyper-
splenism have developed in some of these patients. 
This syndrome has affected multiple members of 
at least one kindred. 
Quantitation of immunoglobulins in the sera of 
patients with acquired agammaglobulinemia usu-
ally reveals levels of IgG below 500 mg per 100 
ml-higher than those encountered in the sera of 
children with congenital disease. IgA and IgM may 
also be detected in significant quantity in the sera 
of these patients. The IgG may show restricted 
heterogeneity. Lymph nodes lack plama cells, but 
in place of the absent follicles of congenital agam-
maglobulinemia, abiotrophy of the follicles or 
striking follicular hyperplasia may be found. Most 
patients with common, variable agammaglobulin-
emia have B-Iymphocytes in their blood in normal 
or increased numbers [15]. In some patients, these 
B-Iymphocytes are abnormal in in vitro tests in 
that they are unresponsive to the mitogenic signal 
from T -lymphocytes. Other patients have B-Iym-
phocytes which respond normally to the T-cell 
signal by enlargement, division, formation of rough 
endoplasmic reticulum, and gamma globulin syn-
thesis. However, the newly synthesized gamma 
globulin is not secreted. The secretory bloc is 
associated with a failure of heavy-chain glycosyla-
tion, a penultimate event in normal B-Iym-
phocytes prior to gamma globulin secretion. Other 
patients have been described in whom normal 
B-cells are encountered. The normal functioning of 
B-Iymphocytes is suppressed by the plasma or 
T-cells from such patients. Thus, a diverse variety 
of defects have been uncovered in the B-Iym-
phocytes of patients with this form of agamma-
globulinemia. The biochemical bases for these 
defects remain to be elucidated. 
Patients with primary acquired agammaglobu-
linemia have an unusually high incidence of" auto-
immune" diseases, such as pernicious anemia, 
vitiligo, hemolytic anemia, and so on [16]. 
Although patients with lymphoma or chronic lym-
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phocytic leukemia may present with or develop 
hypogammaglobulinemia, the progression of pri-
mary acquired agammaglobulinemia to lym-
phoreticular malignancy has only rarely been doc-
umented. There is a frequent association between 
thymoma and acquired agammaglobulinemia. 
Patients with thymoma and agammaglobulinemia 
may show progressive deterioration of cellular 
immunity and a regenerative anemia. 
DERMATOLOGIC ASPECTS: TRANSIENT, CONGENITAL, 
SPORADIC, AND ACQUIRED AGAMMAGLOBULINEMIAS 
One of the most common primary manifesta-
tions is recurrent and severe furunculosis, usually 
caused by Staphylococcus aureus. Severe cicatri-
zation of the skin may result from repeated epi-
sodes of pyoderma. Drug eruptions, poison ivy, 
angioedema, and eczema occur frequently in 
patients with agammaglobulinemia. However, a 
wheal-and-flare reaction cannot be elicited. 
The course of the viral exanthems is usually 
normal in children with agammaglobulinemia. 
Extensive manifestations of verruca vulgaris have 
been noted in a few cases of dysgamma-
globulinemia (usually absence of IgA and IgG with 
elevated IgM). 
Cutaneous and visceral granulomas of unknown 
cause frequently complicate acquired agamma-
globulinemia in adults. A dermatomyositis-like 
syndrome has been observed later in the course of 
the disease in several children with agammaglobu-
linemia. The skin over extensor surfaces of the 
joints develops the typical violaceous rash of der-
matomyositis. Brawny, almost ligneous edema and 
induration of the subcutaneous tissues occur. This 
complication has been uniformly fatal after a 
period of months. Persistent shedding of ECHO 
virus has been found in patients with this der-
matomyositis-like syndrome. 
CONGENITAL THYMIC APLASIA (DIGEORGE'S 
SYNDROME) 
During the 6th week of embryonic life, the 
thymic primordium arises from the floor of the 
third pharyngeal pouch and to a lesser extent from 
the fourth pharyngeal pouch. The endodermal 
epithelial masses rapidly elongate, moving down 
into the neck, and fuse in the midline behind the 
thyroid primordium in the 8th week of embryonic 
life. By the 12th week, the gland comes to occupy 
its ultimate position in the anterior mediastinum, 
the epithelial cells have formed Hassall's corpus-
cles, and the primordium has been invaded by 
proliferating lymphoblasts. 
While the thymus gland is forming, the parathy-
roid glands arise simultaneously from the third and 
fourth pharyngeal pouches and start their migra-
tion to a position posterior to the thyroid primor-
dium. During this same period, the nasomedial 
processes fuse to form the philtrum of the lip and 
the ear tubercles around the hyomandibular cleft 
form into the external ear. 
DiGeorge observed that a congenital anomaly 
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may result from the failure of embryogenesis of the 
entodermal derivatives of the third and fourth 
pharyngeal pouches, namely, aplasia of the para-
thyroid and thymus glands. This abnormality has 
not shown a familial incidence and does not appear 
to be hereditary but seems rather to be the 
consequence of some intrauterine accident. All 
infants with this syndrome thus far studied have 
manifested neonatal tetany. The hypocalcemia 
tends to ameliorate with age during the first year of 
life. Hypertelorism, a shortened lip philtrum, low-
set, notched pinnae, and nasal clefts cause these 
infants to resemble each other. In addition, anom-
alies of the great blood vessels are almost always 
present; tetralogy of Fallot and right-sided aortic 
arch are the most commonly encountered defect. 
Infants with thymic aplasia who survive the 
neonatal period exhibit untoward susceptibility to 
viral, fungal, and bacterial infections which may 
ultimately be overwhelming. At autopsy, some 
parathyroid tissue and a miniature thymus gland 
may be found in an ectopic position upon careful 
sectioning of the neck organs. Nephrocalcinosis has 
been encountered in over half the cases at prosec-
tion. The lymphoid tissue, bone marrow, spleen, 
and gastrointestinal tracts have normal numbers of 
plasma cells, and cortical germinal centers are 
normal, if not exuberant, in the lymph nodes. The 
subcortical "thymus-dependent region" exhibits 
moderate to severe depletion of lymphocytes so 
that the reticulum cells appear to be prominent in 
this area. The lymphoid sheaths of the spleen are 
also depleted of lymphocytes. There are no T -cells 
in the blood. 
Antibody responses to primary stimuli are nor-
mal. Serum concentrations of immunoglobulins 
are normal. However, delayed hypersensitivity is 
not manifested to common antigens such as Can-
dida or streptokinase. Sensitization to dinitro-
fluorobenzene (DNFB) is unsuccessful or yields a 
weakly positive result. Skin allograft rejection has 
been absent or abnormally delayed. Lymphocyte 
transfer tests and macrophage-immobilizing factor 
synthesis are abnormal. The peripheral blood lym-
phocytes respond poorly, if at all, to in vitro 
stimulation by PHA, allogenic cells, and antilym-
phocyte serum [17]. 
All these deficits in in vitro and in vivo lym-
phocyte function were dramatically reversed by 
transplants of fetal thymic tissue into 2 children 
with this syndrome. Increase in lymphocyte count, 
population of thymus-dependent areas, normal 
skin allograft rejection, normal responses to intra-
dermal antigens and to DNFB, as well as normali-
zation of PHA response in vitro, have been docu-
mented. Furthermore, these corrections have 
become apparent as early as 48 hr after the 
transplants, which suggests that lymphocytic rec-
ognition mechanisms in these infants are intact 
and that fetal thymus tissue provides some critical 
element in their responsiveness [18,19]. 
More recently, it has been appreciated that an 
incomplete form of the syndrome results in a 
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clinically more benign course. Death may occur 
later in childhood from cardiac anomalies rather 
than from infectious complications. However, even 
in the more severe forms of the defect, some T-cell 
function is acquired in time, by the 4th or 5th year 
of life. 
SEVERE COMBINED IMMUNODEFICIENCY 
In 1950, Glanzmann and Riniker described 2 
unrelated infants who succumbed to overwhelming 
infection during the second year of life after a . 
life-long succession of serious infections, including 
intractable diarrhea, thrush, and peristent morbil-
liform rash. They noted persistent and profound 
lymphopenia in these 2 infants and thus called this 
disease essential lymphocytophthisis. Over 200 
cases of this disease have by now been described. It 
may prove to be the most common genetic defect in 
immunity. It has been estimated that 10% of 
extraneonatal infant mortality is caused by this 
syndrome [20]. 
In the early European descriptions, it appeared 
that the disease was transmitted as an autosomal 
recessive phenomenon; consanguinity among ap-
proximately one-third of patients of affected chil-
dren was documented. Further studies of affected 
families in America and Europe strongly suggested 
a possible X-linked mode of transmisssion. This 
supposition was based on the documentation of 
affected males in three generations, the appear-
ance of the disease in sons of identical twin 
mothers, and the appearance of the disease in sons 
of a single mother with different fathers. The fact 
that the phenocopy can arise from two different 
modes of inheritance, both autosomal and X-
linked recessive, probably accounts for the 3: 1 ratio 
of males and females observed in the reported 
cases. Several females and males with the autoso-
mal recessive form of the disease are deficient in 
the enzyme adenosine deaminase. The significance 
of this enzyme deficiency is not yet completely 
understood although it appears to cause the 
immunodeficiency. 
For purposes of clinical descriptions, it is proba-
bly easiest to lump the two genetic types because 
there is no discernible difference in their clinical 
course; nor, for that matter, can they be separated 
on grounds of the morbid anatomy of the disease. 
In any case, infection starts early, at between 3 and 
6 months of age, and a rapid succession of debili-
tating infections brings about early demise; death 
within the first 2 years of life is the rule. Almost all 
infants with this disease have loose, watery chronic 
diarrhea. Frequently, stool cultures grow out Sal-
monella or enteropathic Escherichia coli strains. 
Pulmonary infection is also almost universally 
encountered. Abscesses of the lung containing 
Pseudomonas aeruginosa are a common cause of 
death, as is pneumonitis due to Pneumocystis 
carinii. Extensive moniliasis of the mouth or dia-
per area that persists beyond the neonatal period is 
often a first sign of the disease. Thrush is usually 
present even before any antibiotic therapy is insti-
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tuted. Furthermore, these infants are incapable of 
limiting and terminating the most benign viral 
infections. Death has resulted from generalized 
chickenpox, measles with Hecht's giant cell pneu-
monia, and, in a few instances, from cytomegalovi-
rus and adenovirus infection. Vaccination results 
in progressive, ultimately fatal vaccinia infection. 
BCG inoculation has also resulted in progressive 
BCG infection. 
These infants are prey to all kinds of viral , 
bacterial, fungal , and protozoan infections. This 
susceptibility is usually manifested by skin, pul-
monary, and gastrointestinal infections. Ulti-
mately, the infants fail to thrive, and the lack of 
weight gain causes the appearance of runting, 
which may be aggravated by protein-losing 
enteropathy . 
In 1958, the Swiss workers pointed out that 
agammaglobulinemia is a prominent feature of 
this disease entity. Serum concentrations of immu-
noglobulins are very low and the IgG may exhibit 
restricted heterogeneity. No antibody synthesis 
can be detected. Acute phase-reacting proteins rise 
in the usual manner with infection. Clq, a compo-
nent of the complement system, has been reported 
to be low in some cases, but this is not an 
invariable finding. Interferon synthesis is normal. 
At times, normal immunoglobulin levels are found 
and M components may be present [21]. 
Leukopenia is usually encountered because of 
the low lymphocyte counts, usually less than 2000 
per mm 3 . The lymphocyte count may be variable 
and decline from initial normal neonatal levels 
(greater than 3000 per mm 3) to more profoundly 
lymphopenic levels. A single lymphocyte count is , 
nonetheless, not a reliable index of the disease , as 
normal lymphocyte counts can be observed. Gran-
ulocytes and platelets are normal, although no 
leukocytosis may occur in the presence of overt 
infection. Eosinophilia is common , and abnormal 
granulation of eosinophils has been reported. 
The bone marrow is uniformly deficient in 
plasma cells , lymphocytes, and lymphoblasts. 
Bone marrow of normal infants contains up to 20% 
cells in the lymphocytic series. This deficiency 
may well be the primary defect in this disease: the 
failure of formation of an immunopotential cell 
that originates from the marrow . Lymph node 
biopsy, when feasible, exhibits a complete lack of 
germinal elements , plasma cells , and lymphocytes. 
Only the stroma of the node is seen to contain 
occasional mast cells and eosinophils or, rarely, 
small collections of lymphoid cells without any 
apparent organization. 
None of the parameters of delayed sensitivity 
can be elicited in these infants. They are unrespon-
sive to Candida antigen in the presence of overt, 
chronic Candida infection. They cannot be sensi-
tized to DNFB. The peripheral blood lymphocytes 
are completely unresponsive to PHA or allogenic 
stimulation. Skin grafts are accepted with no 
microscopic or macroscopic signs of rejection. At 
autopsy, no lymphoid tissue is found in the spleen , 
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tonsils, appendix, or intestines. The thymus gland 
is found with difficulty in the neck, the gland 
usually having failed to descend in the normal 
manner into the anterior mediastinum. It weighs 
less than 1 gr and is composed of primordial 
spindle-shaped cells, occasionally forming swirls or 
rosettes. No Hassall's corpuscles and few, if any, 
lymphocytes are present. The dysplasia of the 
thymus gland is the uniformly characteristic fea-
ture of this entity. 
Very little inflammatory reaction is seen in 
extensively infected tissue, such as lung, skin, or 
intestines. Intravascular coagulation has been 
noted in a few infants who died of a complicating 
hemolytic-uremic syndrome. Gamma globulin 
therapy is of no avail in averting the inexorably 
fatal outcome of this defect. Attempts to restore 
immunologic competence with thymus grafts, fetal 
hemopoietic cells, and bone marrow transplants 
have in the past uniformly failed to achieve this 
end . Although transitory beneficial effects have 
been achieved, the risk is grave, graft-versus-host 
disease having resulted in several fatalities. This 
complication has arisen following bone marrow or 
whole blood transfusion. In one case, persistence of 
transplacentally acquired maternal lymphoid cells 
was recorded. In any event, a characteristic macu-
lopapular rash starting on the face heralds the 
onset of graft-versus-host disease about 7 days after 
the administration of immunocompetent cells. The 
rash spreads rapidly to involve ultimately all skin 
surfaces, including the palms and soles. Throm-
bocytopenia , leukopenia, jaundice, and anasarca 
follow in quick succession, and the bone marrow 
aplasia leads to death from massive hemorrhage by 
the 12th or 14th day . 
On the basis of experimental observations, it has 
been reasoned that transplants of bone marrow 
cells as a source of immunopotential stem cells 
would restore immunologic competence to these 
infants. It is also apparent from the aforemen-
tioned misadventures that it would be necessary to 
circumvent the difficulties of graft-versus-host dis-
ease by administering completely histocompatible 
bone marrow cells . This remarkable feat has now 
been achieved in at least 24 patients with severe 
combined immunodeficiency [22-24]. 
Transplants of histoidentical bone marrow from 
sibling donors equip such infants with T - and 
B-cell function, and their lymphoid chimerism can 
be readily demonstrated . Despite HL-A identity 
between bone marrow donors and recipients, some 
degree of graft-versus-host reactivity is almost 
invariable noted, but its course is less severe and 
does not have a fatal issue. In 1 of these cases, the 
donor and recipient were ABO-incompatible, and 
the recipient had an aplastic crisis which was 
treated with a second bone marrow transplant 
which in turn produced complete erythrocyte and 
leukocyte chimerism in the recipient. Thus far, 
such transplants have not succeeded through the 
barrier of a positive mixed lymphocyte reaction. 
Some infants with severe combined immunode-
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ficiency have normal levels of one or all immuno-
globulins. This form of lymphopenia with normal 
immunoglobulins has often been designated N e-
zelof's syndrome, after the investigator who termed 
the defect "aplasie lymphocytaire normoplasmo-
cy-taire et normoglobulinemie." Indeed, abundant 
numbers of plasma cells are found in the spleen, 
intestine, and elsewhere at autopsy, along with 
thymic dysplasia and lymphoid tissue depletion. 
The clinical course of these infants may be slightly 
less malignant, but death by the third year of life 
has been the rule. A high incidence of Coombs-
positive hemolytic anemia has been encountered 
together with other autoimmune phenomena. Anti-
genic stimulation with phage particles, bacterial 
toxins, and so on does not result in a normal or even 
detectable antibody rise; and only 1 of these in-
fants had a decent antibody response to poliomye-
litis virus. It appears that the immune response in 
these infants is grossly abnormal despite normal 
immunoglobulin levels. 
Several infants have also been reported to have 
only IgM or IgG and IgA in their serum. It may be 
spurious to classify all these variations by the 
presence of one or another immunoglobulin in the 
serum, as variations in immunoglobulin pattern 
have been observed in siblings of an affected 
kindred. Consequently, the Nezelof syndrome 
should be included in the group of severe combined 
immunodeficiency. 
In yet another form of stem cell immunodefi-
ciency, there is total myelopoietic failure, so-called 
reticular dysgenesia . The few infants with this 
disease have died within the 1st week of life of 
overwhelming staphylococcal sepsis. In addition to 
the characteristic thymic dysplasia, lymphopenia, 
and lymphoid depletion , there are severe neutro-
penia and depletion of myeloid precursors from the 
marrow [25]. 
DERMATOLOGIC ASPECTS OF T -C ELL DEFICIENCY : 
THYMIC APLASIA AND COMBINED IMMUNE 
DEFICIENCY 
Besides pyoderma, a frequent early manifesta-
tion of agammaglobulinemia, infants with failure 
of thymic embryogenesis manifest other der-
matologic complications. Extensive cutaneous and 
oral moniliasis, persisting beyond the neonatal 
period, is the most common presenting complaint 
in these infants. Persistent morbilliform rash prob-
ably is suggestive of smouldering measles infection 
which terminates fatally. When vaccinated, these 
infants develop fatal progressive vaccinia gan-
grenosa. No therapy has been of any avail in these 
com plications. Hemorrhagic varicella also has 
been seen. 
In contrast to patients with agammaglobulin-
emia who have normal or near normal first and 
second set rejection, infants with faulty thymic 
development accept homografts and manifest no 
signs of rejection macroscopically or microscopi-
cally. 
As mentioned above, infants with T-cell defects 
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are very susceptible to graft-versus-host disease 
when given exogenous, immunocompetent cells 
from blood, spleen, bone marrow, or fetal liver. The 
reaction first is manifested 4 days after receiving 
such cells with fever, which is exquisitely sensitive 
to antipyretics, and maculopapular rash which, 
like measles, starts on the face and spreads to 
involve the trunk and extremities, including the 
palms and soles. Protein-losing enteropathy, diar-
rhea, hemolytic anemia, and thrombocytopenia 
result in death by exsanguination. 
WISKOTT-ALDRICH SYNDROME 
The Wiskott-Aldrich syndrome is characterized 
by eczema, thrombocytopenia, and recurrent in-
fections. Inheritance of the syndrome is X-linked. 
Affected boys rarely survive beyond the first dec-
ade of life, as overwhelming infection, hemorrhage, 
or lymphoreticular malignancy shortens the life 
expectancy. Both gram-positive and gram-nega-
tive bacteria, as well as viruses and fungi, are the 
cause of severe infections. There appears to be a 
progressive deterioration of thymus-dependent cel-
lular immunity with concomitant changes in the 
histopathology of lymph nodes which show pro-
gressive depletion of the paracortical area in older 
surviving patients. Serum IgM concentration is 
usually low, but IgG and IgA levels are normal or 
elevated. Isohemagglutinins are regularly absent 
from the serum. This observation suggested a 
specific inability to respond to polysaccharide 
antigens. This has now been demonstrated quite 
conclusively with A and B substances, Salmonella 
Vi lipopolysaccharide, and so on. No unifying 
hypothesis explains the disparate elements of this 
disease. Nevertheless, most aspects of the syn-
drome have been ameliorated by the administra-
tion of transfer factor obtained from dialysates of 
normal donor lymphocytes [26-28]. 
HEREDITARY ATAXIA-TELANGIECTASIA 
Hereditary ataxia-telangiectasia is transmitted 
in an autosomal recessive mode. Affected infants 
are first noted to be ataxic and develop choreoa-
thetoid movements and pseudopalsy of eye move-
ments during infancy. The telangiectasias appear 
later, at 5 or 6 years, or even not until adolescence. 
They invariably involve the conjunctival and other 
exposed body areas such as the face, ear pinnae, 
eyelids, and arms. Progressive sinopulmonary in-
fection also appears later in the course. Death from 
chronic respiratory infection or lymphoreticular 
malignancy is common in the second or third 
decade of life. 
About 80% of patients with ataxia-telangiec-
tasia lack both serum and secretory IgA. In some 
patients, antibody to IgA and rapid catabolism of 
injected, radioactively labeled IgA are noted. All 
patients with ataxia-telangiectasia exhibit a 
defect in cellular immunity. The thymus gland is 
dysplastic or hypoplastic, and there is depletion of 
thymus-dependent areas. Delayed hypersensitiv-
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ity, in vitro response of blood lymphocytes to PHA, 
and allograft rejection are blunted [29]. 
IMMUNODEFICIENCY WITH SHORT-LIMBED 
DWARFISM 
Short-limbed dwarfism and one of its variants, 
cartilage-hair hypoplasia, are associated with T-
cell defects in particular. Lymphopenia and dimin-
ished in vitro responses of lymphocytes to PHA 
and specific antigens have been noted. In several 
cases individuals have had either fatal or very 
severe varicella or vaccinia infections [30]. 
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DISCUSSION 
Krueger: The group of patients that you report with 
eczematous, recurrent staphylococcal hyper-IgE must 
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represent a part of the spectrum of this type of disorder. I 
say this because Dr. Hill , myself, and others have seen 
and reported patients with eczema, recurrent staphylo-
coccal infections, normal IgE levels, and abnormal neu-
trophil function. Further we recently reported 3 cases of 
subjects with eczema, recurrent staphylococcal infec-
tions, normal IgE, and abnormal neutrophil functions 
only when active infections were ongoing. 
Buckley: Those are interesting observations. Dr. 
Snyderman has found defects either in monocyte or in 
polymorphonuclear chemotaxis, or both, in our patients 
with the hyper-IgE syndrome, but there has been no 
consistent defect. It is our feeling that these are second-
ary phenomena in these patients and do not represent a 
primary immune defect. Some of our patients have had 
no chemotactic abnormalities. We have not evaluated the 
effect of intercurrent infection on the chemotactic abnor-
malities. 
Cohen: The association of elevated IgE levels with skin 
involvement, e.g. , in eczematous processes , atopic der-
matitis, Wiskott-Aldrich syndrome, gives reason to won-
der which, if either, is cause and which effect; is IgE 
production a response to inflammation, especially where 
there is a loss of or aberration in T-cell control? In infants 
and young children with atopic dermatitis we often see a 
tendency for them to demonstrate immediate skin test 
hyper-reactivity, a multiplicity of positive reactions with-
out apparent relation to the test allergens as possible 
causative factors. In adults the delineation of two groups, 
one with and one without demonstrably positive immedi-
ate intracutaneous test reactions, might help to clarify 
some relevant questions. Is it known whether with age or 
duration of the eczematous process there is a decline in 
skin test reactivity and/or a change in IgE levels? Is 
diminished skin test response a function of corresponding 
IgE type antibody or of local events, i.e. , lichenification; 
do mast cells vary either in numbers or quality with 
either age or chronicity of the skin involvement? 
Buckley: I do not feel that the elevated IgE in the 
hyper-IgE patients is secondary to skin disease, since a 
number of our patients had no dermatitis at the time we 
evaluated them, yet had extremely elevated serum IgE 
concentrations. There does not appear to be any quan-
titative relationship between the amount of serum IgE 
and the degree of delayed cutaneous anergy or depressed 
in vitro lymphocyte responsiveness to antigens, although 
we may not have the best methods to look at this question 
yet. 
Kirkpatrick: With respect to the chicken and the egg 
question of Dr . Cohen, there is a fll;Il1ily reported in the 
Annals of Internal Medicine by Van Scoy et al in which 
family members had elevated serum IgE but did not have 
unusual susceptibility to infection. Thus, the IgE level 
may serve as a marker, but is not necessarily the 
consequence of chronic or recurrent infection. 
Drs . Peter Sohnle and Michael Frank and I have been 
performing immunofluorescent studies of the cutaneous 
lesions in patients with chronic mucocutaneous candidia-
sis . The biopsies of the affected areas show intense 
mononuclear cell infiltrations even in patients with 
severely impaired cell-mediated immunity. With immu-
nofluorescence, we have found intense staining for C3 and 
properdin at the basement membrane zone. None of the 
tissues have been positive for C4 or any immunoglobulin . 
In addition, Candida organisms will activate the alterna-
tive complement pathway, leading to the production of 
chemotactic factors. We suspect that this reaction occurs 
in vivo and is involved in production of cutaneous 
inflammation. We believe that patients with chronic 
mucocutaneous candidiasis may be predisposed to the 
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infection be~ause of the defect in cellular immunity. 
However, production of the lesions occurs through an -
other mechanism. 
Buckley: I am not certain that we can say the 
hyper-IgE patients have primary defects in delayed 
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hypersensitivity , since their in vitro mitogen responsive-
ness is normal and since our newest patient, the young 
infant, has a normal delayed cutaneous response to 
Candida antigen despite having continuing problems 
with oral moniliasis . 
